Table 2

Neurodevelopmental outcomes at 24 months

No episodes of hypoglycaemia At least one episode of hypoglycaemia (<2.6 mmol/L) p Value* Two or more episodes of hypoglycaemia (<2.6 mmol/L) p Value* Three or more episodes of hypoglycaemia (<2.6 mmol/L) p Value*
BSID-III scores (mean, SD)
 Cognitive subscale99 (19)98 (18)0.81396 (21)0.49983 (25)0.030
 Language subscale93 (20)92 (21)0.87587 (23)0.34971 (26)0.020
 Socioemotional subscale99 (20)99 (22)0.91593 (25)0.64074 (23)0.004
 Motor subscale97 (18)97 (18)0.97694 (22)0.31686 (30)0.385
Adverse outcomes in survivors (n, %)
 BSID cognitive or language<707/70 (10)4/34 (12)0.7473/20 (15)0.6863/9 (33)0.082
 Blindness0 (0)1/34 (3)0.3271/20 (5)0.2221/9 (11)0.114
 Deafness1/70 (1)3/34 (9)0.1013/20 (15)0.0332/9 (22)0.033
 Cerebral palsy5/70 (7)4/34 (12)0.4703/20 (15)0.3692/9 (22)0.179
 Any disability8/70 (11)7/34 (21)0.2426/20 (30)0.0745/9 (55)0.005
Composite outcome (n, %)
 Death14/84 (17)4/38 (11)0.4252/22 (9)0.5152/11 (18)1.0
 Death or disability22/84 (26)11/38 (29)0.8278/22 (36)0.4267/11 (64)0.031
  • *p Value compared with no hypoglycaemia group.

  • BSID-III, Bayley Scale of Infant and Toddler Development III.